The Delta 4 diode array phantom (Scandidos, Uppsala, Sweden) was evaluated for verification of segmental intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) on an Elekta linear accelerator (Crawley UK). The device was tested for angular sensitivity by irradiating it from 36 different gantry angles, and the responses of the device to various step-and-shoot segment doses and dose rates were evaluated using an ionisation chamber as a comparison. The phantom was then compared against ionisation chamber and film results for two prostate and pelvic nodes IMRT plans, two head and neck IMRT plans and two lung VMAT plans. These plans were calculated using Pinnacle 3 (Philips Radiation Oncology Systems, Madison, WI). The uniformity of angular response was better than 0.5% over the range of gantry angles. The uniformity of response of the Delta 4 to different segment monitor units and dose rates was better than 0.5%. The assessment of the IMRT and VMAT plans showed that the Delta 4 measured a dose within 2.5% of the ionisation chamber, and compared to film recorded a slightly larger region (range -2% to +7%) agreeing with the planned dose to within 3% and 3 mm. The Delta 4 is a complex device and requires careful benchmarking, but following the successful completion of these measurements, Delta 4 has been introduced into clinical use.
Introduction
Complex radiotherapy treatment plans such as those involving intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) require dosimetric verification before clinical delivery (Ezzell et al 2003) . The Delta 4 phantom (Scandidos, Uppsala, Sweden) offers a convenient means of achieving this. It consists of 1069 p-type Silicon diodes in a crossed array inside a cylindrical polymethylmethacrylate (PMMA) phantom, and associated computer software allows the user to compare the measured dose distribution for a complete treatment plan with the dose distribution predicted by the treatment planning system. The diodes are cylindrical, have an area of 0.0078 cm 2 , and are spaced at 0.5 cm intervals over the central 6 x 6 cm of the planes and at 1 cm intervals over the remainder of the central 20 x 20 cm of the planes. The crossed planes are achieved by means of a main detector board which passes through the entire diameter of the phantom, and two wing detector boards which are separated to allow the main detector board to pass between them. The phantom itself has a diameter of 22 cm and length of 40 cm ( Figure 1 ). The device records measured dose in relation to the individual accelerator pulses by using a trigger signal from the accelerator, thereby facilitating time-dependent four-dimensional applications.
Gantry angle is independently sensed by means of an inclinometer attached to the gantry or accelerator head.
This allows the device to identify which control point of a dynamic arc delivery is being delivered, so that the measured dose can be associated with this control point, and the appropriate correction for gantry angle applied.
The verification process requires the treatment plan in consideration to be recalculated on a CT scan of the phantom. An artificial dataset consisting of a uniform PMMA-equivalent cylinder is used rather than a real CT scan, so as to avoid errors due to the appearance of the diodes on the CT scan. Calibration of the phantom once a year is recommended. A three-dimensional dose option is available which takes the measured dose in the planes and then rescales the planned dose accordingly to give an indication of the dose that would be measured between the two detector planes. This has not been used in this study as it is intended for interpretation and visualisation of results rather than as a direct measurement.
As this is a new device with new technology, an evaluation and benchmarking process is desirable before clinical use. Furthermore, since the device is not strictly independent of the accelerator, due to the trigger signal obtained from the accelerator, it is important to ensure that the device functions correctly for the accelerator in use. This study therefore evaluates the phantom by means of basic performance tests and by comparing its results with those produced by the more established methods of ionisation chamber and film (Bedford et al 2008b) . Segmental (step and shoot) IMRT and VMAT are specifically considered, on Elekta linear accelerators.
Methods

Performance tests
Several basic tests were carried out to examine specific performance characteristics of the Delta 4 phantom.
These were not intended to be an exhaustive characterisation of the device, but rather to evaluate those features of the phantom in which greater confidence was required. 
Angular sensitivity
The diodes in the phantom have an inherent angular sensitivity to radiation. This is corrected for by the Delta 4 software, which compensates according to the known gantry angle of the beam being delivered. In order to check the accuracy of this correction, 36 10.4 x 9.6 cm beams with 200 MU were delivered at 10° gantry intervals around the phantom. (10.4 x 9.6 cm on a Beam Modulator head is the equivalent of a 10 x 10 cm field on a normal head.) In order to measure the response of the phantom without the attenuation of the couch, the measurements were taken with the phantom in three positions. Firstly, with the phantom upright in its normal position, the responses of the Delta 4 to gantry angles 270° to 90° were measured. The phantom was then turned first onto one side and then onto the other, and gantry angles 270° to 90° used to irradiate from the directions corresponding to 90° to 270° through 180° in normal operation.
The response of the phantom was measured using the daily output correction facility of the Delta 4 .
The ( 1) This is normally used for setting up the phantom according to the daily output of the accelerator. However, for a fixed planned distribution, D TPS , the relative response, R, of the Delta 4 is given by:
which was used in this case for evaluation of the angular behaviour.
Four measurements were taken at each gantry angle to assess the reproducibility and uncertainty.
Ideally, the output of the accelerator should have been simultaneously measured with an ionisation chamber to ensure that any variation in Delta 4 output was entirely due to the device itself and not due to accelerator output variation, but due to the variation in gantry position, this was not feasible. However, the response of the phantom to irradiation from the cardinal angles was measured with the phantom both upright and lying down. (For example, the response to irradiation from the top of the phantom was measured with gantry angle 270° and the phantom lying down on its left side, with gantry angle 0° and the phantom standing up, and with gantry angle 90° and the phantom lying down on its right side.) This provided a measure of the uncertainty resulting from the phantom positioning and possible variation of the accelerator with gantry angle.
Linearity of segment dose
An earlier version of Delta 4 software was found to be inaccurate for multiple low-MU IMRT segments. The linearity of the Delta 4 for delivery of segmental beams was therefore checked. A series of 10.4 x 9.6 cm beams were delivered at gantry angle 0°. The beams were for one segment with 80 MU, two segments with each and 32 segments with 2.5 MU each, covering the range of segment sizes encountered in IMRT delivery.
The response of the phantom, R, was measured using the daily output correction factor as in section 2.1.1 above. A 0.6 cm 3 Farmer ionisation chamber (Saint Gobain Crystals and Detectors, Reading, UK) was positioned under 3 cm of Solid Water (Radiation Measurements, Inc., Middleton, WI) centrally beneath the Delta 4 phantom so as to correct for any variation in accelerator output, which might occur at the small segment doses. For an ionisation chamber charge of C, the true response of the Delta 4 , R C , excluding any accelerator variation, was taken as:
Four measurements were taken for each beam to assess the uncertainty in the measurement. The value of R C was calculated for each measurement, and the mean taken as the overall Delta 4 response.
Dose rate dependence
The output of the Delta 4 was examined as a function of dose rate. A series of 10.4 x 9.6 cm beams were delivered at gantry angle 0°. The dose rate of the beam was set to 600 MU/min, 300 MU/min, 150 MU/min, 75 MU/min and 37 MU/min. The output of the Delta 4 was measured using the daily output correction factor.
A Farmer chamber was also used to simultaneously correct for the accelerator output as in 2.1.2 above. Ion recombination within the ionisation chamber was measured at 600 MU/min and 37 MU/min and found to be around 0.5% in both cases, which was expected, as the dose per pulse of the Elekta accelerator is constant at all dose rates. Ion recombination was determined to be a constant factor for the dose rate dependence measurements and was subsequently neglected. Four measurements were taken for each beam to assess the uncertainty in the measurements.
Comparison studies
Having established that the basic performance of the Delta 4 was satisfactory, the device was compared with the more traditional IMRT plan verification methods using ionisation chamber and film in a water-equivalent phantom. Six treatment plans were considered: two prostate and pelvic nodes IMRT plans, two head and neck IMRT plans and two lung VMAT plans. The prostate and pelvic nodes plans consisted of five segmental (step and shoot) beams, with approximately 10 segments per beam (Adams et al 2004) , while the head and neck plans consisted of seven beams with approximately 10 segments per beam. The VMAT plans each consisted of a single gantry arc (Bedford et al 2008a) . The IMRT plans were computed on the Pinnacle 3 treatment planning system (Philips Radiation Oncology Systems, Madison, WI), and the VMAT plans were generated using an in-house program AutoBeam and a final dose calculation was made within Pinnacle 3 . The Pinnacle 3 treatment planning system had previously been fully commissioned for IMRT (Bedford et al 2003 (Bedford et al , 2004 . As the use of the planning system with the Delta 4 involved calculating dose in PMMA, some additional measurements of dose for various depths and field sizes were made to ensure that Pinnacle 3 was performing this correctly.
The six treatment plans were verified using an ionisation chamber and film, prior to patient 
where D IC, CUBE was the dose measured by the ionisation chamber, corrected for the daily output of the accelerator. The value of ∆D IC was required to be such that -3% ≤ ∆D IC ≤ +3%.
The film measurements were made using whole sheets of 30.5 cm x 25.4 cm EDR2 film (Eastman Kodak, Rochester, NY), with the exception of one of the head and neck cases and one of the lung cases (cases 3 and 6 respectively), where the film measurements were made with whole sheets of 25.4 cm x 20.3 cm Gafchromic EBT film (International Specialty Products, NJ). The film was located coronally in the same Solid Water stack as the ionisation chamber. The EDR2 film was calibrated by irradiating a separate sheet with the depth dose from a 10 x 10 cm field, and the films were digitised using a Dosimetry Pro Advantage film scanner (Vidar Systems Corporation, Herndon, VA). The EBT film was calibrated using a batch calibration and each film was scanned before and after irradiation using an Expression 1680 Pro flatbed scanner (Seiko Epson Corporation, Nagano, Japan). The films were analysed using OmniPro I'mRT (Wellhöfer-Scanditronix, Schwarzenbruck, Germany) and normalised to a region of homogeneous dose. The gamma index (Γ Γ Γ Γ) for 3% of the dose to the normalisation point and 3 mm was calculated over a rectangular region of interest positioned around the high-dose region (Low et al 1998) . This was a two-dimensional gamma calculation, in which the information in the film plane was compared with the information in the corresponding plane of the calculated dose. For each film, 90% of the region of interest was required to have a gamma value of less than unity. therefore reflected all of the central diode measurements around the isocentre.
The overall response was assessed by selecting the diodes measuring greater than 20% of the isocentre dose, and recording the percentage of these diodes which agreed with the plan to within 3% of isocentre dose and 3 mm. This gamma calculation compared the dose at the discrete diode locations with the three-dimensional dose distribution calculated by the treatment planning system. 
